Open Tender Watch
Menu v
ACCESS EN PT
← Companies Company PT

LABORATÓRIOS PFIZER LDA

NIF 500162166
↓ CSV ↓ JSON
Risk Flags
A1 · Repeat Direct Award €56,458,056 135 contracts
Same supplier receives ≥2 direct awards in 36 months with cumulative value above the CCP Art. 113 §2 statutory cap
HIGH €56,458,056 135 contracts
A2 · Late Publication €29,829,874,558 6,772 contracts
Contract published to BASE more than 10 days after the signing date
LOW €29,829,874,558 6,772 contracts
A5 · Threshold Splitting €18,823,819 222 contracts
Contract value falls within 5% below a procedural threshold (€5K / €20K / €75K / €150K / €5.35M). Score: 35 · Severity: Medium.
HIGH €18,823,819 222 contracts
A6 · Low Competition €6,773,045 73 contracts
Only one bidder participated in a competitive procedure
MEDIUM €6,773,045 73 contracts
A9 · Price Overrun €21,333 5 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
HIGH €21,333 5 contracts
A9 · Abnormal Price Reduction €36,629,926,533 3,688 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
LOW €36,629,926,533 3,688 contracts
B5 · Benford's Law Deviation €983,875,478 4 contracts
Entity's contract values deviate from the Benford leading-digit distribution (chi-square goodness-of-fit, min 20 contracts). Score: 35 (p<0.05) or 55 (p<0.01).
MEDIUM €983,875,478 4 contracts
C3 · Missing Mandatory Fields €15,847,744 196 contracts
CPV code, procedure type, or base price absent for the procedure type, or base price exceeds ±€1 trillion (implausible data entry). Score: 20 · Severity: Low.
LOW €15,847,744 196 contracts

Procurement Network

Aggregated links between this entity and connected counterparties

Public view excludes person-level links and tax identifiers.

Loading network…
Legend Focus entity Public body Company Anonymized individual

Contracts by Contracting Authority

886
€4,993,899,452
624
€1,263,106,038
209
€1,227,738,395
212
€1,216,896,438
1,072
€1,149,909,681
143
€1,075,187,477
222
€1,072,329,340
73
€1,055,805,117
90
€1,047,815,411
291
€1,044,515,760
130
€1,043,365,206
80
€1,042,745,652
100
€1,034,016,470
62
€1,022,876,502
39
€1,012,980,395
387
€1,012,502,146
97
€997,109,581
507
€949,915,644
223
€926,252,911
310
€923,744,593
Page 1 of 5 · 81 authorities
Next →

All Contracts Won

Signal: All A1 · Repeat Direct Award A2 · Late Publication A5 · Threshold Splitting A6 · Low Competition A9 · Price Overrun A9 · Abnormal Price Reduction B5 · Benford's Law Deviation C3 · Missing Mandatory Fields

Page 1 of 1 · 5 contracts

Medicamentos
PT · cc81fec50721dc93d4fb · Ajuste Direto Regime G...
A9 · Price Overrun
€6,286 2025-06-26
Medicamentos
PT · 6cf89f53197da1caebe4 · Ajuste Direto Regime G...
A2 · Late Publication A9 · Price Overrun
€6,286 2025-06-12
Medicamentos
PT · 26f69a871a3c80efbb16 · Ajuste Direto Regime G...
A2 · Late Publication A9 · Price Overrun
€1,615 2025-06-03
AP 764 - Aquisição de Metilprednisolona 1 g Pó p/ Sol inj IM IV
PT · 9345158 · Ao abrigo de acordo-qu...
A9 · Price Overrun A2 · Late Publication
€133 2022-06-23
FI0040/2017 - MEDICAMENTOS ANTIVIRICOS E ANTIFUNGICOS
PT · 4200789 · Ao abrigo de acordo-qu...
A9 · Price Overrun A2 · Late Publication
€7,012 2017-02-15
Overview
Total Value Won
€37,032,726,661
Contracts Won
9,615
Score 328155 · CRITICAL RISK
NIF
500162166
Country
PT
Directors & Officers

Personal data is pseudonymised for public access. Authenticate with a journalist token to view full names and NIFs.

  • A.C. [P-f05d]
    Gerente
    since 2022-11-28
  • F.J. [P-b870]
    Gerente
    since 2025-02-27
  • P.A. [P-9563]
    Gerente
    since 2014-06-26
  • P.G. [P-1249]
    Gerente
    since 2008-04-22
  • R.J. [P-516e]
    Gerente
    since 2021-06-22
  • T.S. [P-c179]
    Gerente
    since 2021-06-22
  • P.W. [P-bd21]
    Sócio
    since 2012-08-13
  • P.W. [P-bd21]
    Sócio
    since 2012-08-30
  • P.S. [P-b820]
    Sócio
    since 2012-08-13
  • P.S. [P-b820]
    Sócio
    since 2012-08-30
  • A.P. [P-1479]
    Gerente
    2009-03-04 → 2016-10-06
  • A.P. [P-1479]
    Gerente
    until 2013-10-15
  • A.C. [P-f05d]
    Gerente
    2014-10-28 → 2021-06-22
  • A.P. [P-6d4c]
    Gerente
    2012-10-26 → 2014-11-24
  • B.G. [P-2ebe]
    Gerente
    2023-04-06 → 2025-12-02
  • C.M. [P-2e72]
    Gerente
    2014-06-26 → 2015-07-03
  • C.M. [P-2e72]
    Gerente
    2021-06-22 → 2022-11-28
  • F.J. [P-b870]
    Gerente
    2012-10-26 → 2014-06-26
  • L.R. [P-b234]
    Gerente
    2017-06-07 → 2019-01-24
  • L.F. [P-9705]
    Gerente
    2009-03-04 → 2012-09-24
  • M.D. [P-6765]
    Gerente
    2021-06-22 → 2023-04-06
  • M.M. [P-70e3]
    Gerente
    2009-03-04 → 2015-07-03
  • S.P. [P-a960]
    Gerente
    2019-02-07 → 2021-02-17
Ownership & Registries

Beneficial ownership data (shareholders, directors, ultimate beneficial owners) is not yet imported. Links below open external public registries.

Registo Comercial (MJ) ↗ RCBE — Beneficial Ownership Register ↗

Full RCBE access requires judicial authentication (CJEU 2022 ruling limits public exposure).

Search in TED (EU procurement) ↗
Phase 7 — ownership layer planned